Multiple Primary Lung Cancers
4 clinical trials · Condition
◉ Watch Multiple Primary Lung Cancers
| Record | Firm | Date |
|---|---|---|
| Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities (NCT04982900) | Ruijin Hospital | 2021-10-01 |
| Evolution of Multiple Primary Lung Cancer (Evolution) (NCT04326751) | Peking University People's Hospital | 2021-01-01 |
| The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density. (NCT04026841) | The First Affiliated Hospital of Guangzhou Medical University | 2019-07-30 |
Track Multiple Primary Lung Cancers automatically
Every clearance here is in the API, with alerts when new ones post.